Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Domestic health study

Cervical cancer screening rates decline among US women

Analysis based on 10 articles · First reported Aug 27, 2026 · Last updated Sep 02, 2026

Sentiment
-20
Attention
2
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The findings may increase demand for cervical cancer screening and HPV vaccination, potentially benefiting companies in diagnostics and vaccines. However, the study itself is unlikely to cause significant market movements, as it is a public health research publication.

Healthcare Biotechnology Pharmaceuticals

A study by researchers at the Medical University of South Carolina's Hollings Cancer Center, published in JAMA Network Open, found that the proportion of US women aged 21-29 who have never been screened for cervical cancer rose from 12.5% in 2005 to 31.9% in 2023, an average annual increase of 5.2%. Among women aged 30-65, the never-screened rate rose from 5.3% to 14.8%. The study, based on National Health Interview Survey data, also noted that regional- and distant-stage cervical cancer incidence increased by over 2% per year since 2017 among women aged 30-64. The authors highlighted disparities, with higher never-screening rates among Asian, Hispanic, and Black women, uninsured women, and those in the South. They also noted that nearly 8 million women aged 21-29 remain unvaccinated against HPV, and almost a third of those have never been screened. The study does not prove causation but underscores missed prevention opportunities.

cnt
The country where the study was conducted; findings indicate a public health concern.
Importance 80.0 Sentiment -20.0
priv
Lead institution conducting the study; its reputation is enhanced by the research.
Importance 80.0 Sentiment 0.0
oth
Cancer center at the Medical University of South Carolina; researchers from here led the study.
Importance 70.0 Sentiment 0.0
per
First author and assistant director at Hollings; her work highlights the screening gap.
Importance 70.0 Sentiment 0.0
oth
Primary data source for the study; its data are used to track health trends.
Importance 60.0 Sentiment 0.0
govactor
Issues screening recommendations; the study highlights gaps in adherence to these guidelines.
Importance 40.0 Sentiment 0.0
ngo
Provides screening guidelines; the study's findings may influence its educational efforts.
Importance 40.0 Sentiment 0.0
govactor
Runs the National Breast and Cervical Cancer Early Detection Program; may see increased need for its services.
Importance 40.0 Sentiment 0.0
govactor
Provided funding for the study; its data on cancer incidence were used.
Importance 30.0 Sentiment 0.0
govactor
Provided funding for the study; not directly affected.
Importance 20.0 Sentiment 0.0
ngo
Mentioned as a provider of sliding-scale screening; may see increased demand.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.